Long‐term safety of a structured transition protocol from parenteral prostanoids to selexipag in pulmonary arterial hypertension

There was no structured method for safely transition from parenteral prostanoids to oral medication. We enrolled 37 idiopathic/hereditary pulmonary arterial hypertension patients receiving triple combination therapy including parenteral prostanoids into structured transition program to oral selexipa...

Descripción completa

Detalles Bibliográficos
Autores principales: Tamura, Yuichi, Furukawa, Asuka, Tamura, Yudai, Yamada, Kenta, Taniguchi, Hirohisa, Fukuda, Keiichi, Kawamura, Akio, Satoh, Toru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052976/
https://www.ncbi.nlm.nih.gov/pubmed/35506073
http://dx.doi.org/10.1002/pul2.12058

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052976/
https://www.ncbi.nlm.nih.gov/pubmed/35506073
http://dx.doi.org/10.1002/pul2.12058

Ejemplares similares